Michel Hamon mainly focuses on Internal medicine, Endocrinology, Receptor, Serotonin and Neuroscience. His studies in Endocrinology integrate themes in fields like 5-HT1A receptor, Agonist, Raphe nuclei, Ipsapirone and Dorsal raphe nucleus. His Receptor study integrates concerns from other disciplines, such as Hippocampal formation, Hippocampus and Central nervous system.
His research in Central nervous system intersects with topics in Neuropathic pain, Pharmacology, Hyperalgesia and Spinal cord. Michel Hamon has researched Serotonin in several fields, including Antidepressant and Dopamine. His Neuroscience research is multidisciplinary, incorporating perspectives in Neurotrophic factors and Cell biology.
His primary areas of investigation include Internal medicine, Endocrinology, Receptor, Serotonin and Pharmacology. His work in 5-HT receptor, Serotonin transporter, Raphe nuclei, Neurotransmitter and Dopamine are all subfields of Internal medicine research. His Endocrinology study combines topics from a wide range of disciplines, such as Agonist, Raphe, Dorsal raphe nucleus and Spinal cord.
His Receptor research incorporates elements of Molecular biology, Hippocampus and Binding site. His work deals with themes such as Pulmonary hypertension and Neuroscience, which intersect with Serotonin. The various areas that Michel Hamon examines in his Pharmacology study include Antidepressant, Agomelatine, Anxiolytic and Opioid.
Michel Hamon mainly investigates Pharmacology, Neuroscience, Internal medicine, Endocrinology and Neuropathic pain. Michel Hamon combines subjects such as Antidepressant, Agomelatine, Agonist, Autoreceptor and Blockade with his study of Pharmacology. His research integrates issues of Synaptic plasticity, Baroreflex, Nociception, Neurotrophic factors and Serotonin in his study of Neuroscience.
His study with Serotonin involves better knowledge in Receptor. Michel Hamon regularly ties together related areas like Ethanol in his Internal medicine studies. His Neuropathic pain research is multidisciplinary, incorporating elements of Sciatic nerve, Chronic pain, Tropomyosin receptor kinase B and Allodynia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension
Saadia Eddahibi;Marc Humbert;Elie Fadel;Bernadette Raffestin.
Journal of Clinical Investigation (2001)
Neurotransmitter Transporters in the Central Nervous System
J. Masson;C. Sagné;M. Hamon;S. El Mestikawy.
Pharmacological Reviews (1999)
Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist.
Allan Fletcher;Elaine A. Forster;David J. Bill;Geraldine Brown.
Behavioural Brain Research (1995)
Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain.
Mustapha Riad;Sylvia Garcia;Kenneth C. Watkins;Nicolas Jodoin.
The Journal of Comparative Neurology (2000)
Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function
Francine Côté;Etienne Thévenot;Cécile Fligny;Yves Fromes.
Proceedings of the National Academy of Sciences of the United States of America (2003)
Immunocytochemical localization of serotonin1A receptors in the rat central nervous system.
Hossein K. Kia;Marie‐Christine Miquel;Marie‐Jeanne Brisorgueil;Geneviève Daval.
The Journal of Comparative Neurology (1996)
Monoamine neurocircuitry in depression and strategies for new treatments.
Michel Hamon;Pierre Blier.
Progress in Neuro-psychopharmacology & Biological Psychiatry (2013)
Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system.
Caroline Gérard;Marie-Pascale Martres;Karine Lefèvre;Marie-Christine Miquel.
Brain Research (1997)
Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brain.
M. Marcinkiewicz;D. Verge;H. Gozlan;L. Pichat.
Brain Research (1984)
Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism.
I Nevo;M Hamon.
Neurochemistry International (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: